US FDA approves GSK's blood cancer treatment

The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the company said on Thursday, clearing the way for its return to the ...
Healio

FDA approves Eydenzelt as biosimilar referencing Eylea

Please provide your email address to receive an email when new articles are posted on . Eydenzelt is approved for four retinal diseases, including wet age-related macular degeneration and diabetic ...

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

FDA approves Tezspire for chronic rhinosinusitis with nasal polyps

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
Cure Today

FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma Treatment

Libtayo is approved for adjuvant treatment in high-risk CSCC patients post-surgery and radiation, showing significant disease-free survival benefits in the C-POST trial. The C-POST trial excluded ...
Healio

FDA approves nerandomilast for idiopathic pulmonary fibrosis

Please provide your email address to receive an email when new articles are posted on . The FDA based nerandomilast’s approval on results from two trials, one of which was the FIBRONEER-IPF trial.
Becker's Hospital Review

FDA approves first new treatment for rare disease in 10 years

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring and breathing difficulties. The approval marks the ...

FDA issues safety alert for radiofrequency microneedling

The U.S. Food and Drug Administration (FDA) is warning consumers, patients and health care providers about the potential risk ...
Nature

FDA approves BTK inhibitor for chronic hives

Novartis has secured FDA approval for its BTK inhibitor remibrutinib (Rhapsido) for the treatment of chronic spontaneous urticaria. Remibrutinib is the sixth BTK inhibitor to market in the US, and the ...
Healthline

Generic Abortion Pill As Effective As Mifepristone. Here’s How to Access It

Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...
Monthly Prescribing Reference

Rinvoq Receives FDA Approval for Updated IBD Indications

The updated indications state that if TNF blockers are clinically inadvisable, patients may still be administered Rinvoq if they have previously received at least 1 approved systemic therapy. The Food ...
National Review

FDA’s Approval of Mifepristone Generic Raises Troubling Questions

New Mexico’s ‘Free’ Child Care an Attempt to Cover for Past Failures The Virtue of Liberty: A Response to the NatCons Trump Administration Says Drug-Boat Strikes Are Not Really ‘Hostilities,’ as Death ...